Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17426 | 600 | 37.7 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
17426 | 1 | IRX 2//IMMUNE SUPPRESSOR CELLS//SERV 151Z2 | 600 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IRX 2 | authKW | 363502 | 2% | 71% | 10 |
2 | IMMUNE SUPPRESSOR CELLS | authKW | 356237 | 1% | 100% | 7 |
3 | SERV 151Z2 | address | 178112 | 1% | 50% | 7 |
4 | IMMUNE REGRESSION | authKW | 101782 | 0% | 100% | 2 |
5 | TUMOR BEARERS | authKW | 67853 | 0% | 67% | 2 |
6 | ACUTE NON LYMPHOTIC LEUKEMIA | authKW | 50891 | 0% | 100% | 1 |
7 | ADVANCED BASAL CELL CARCINOMA ABCC | authKW | 50891 | 0% | 100% | 1 |
8 | AN GANG GEN HOSP | address | 50891 | 0% | 100% | 1 |
9 | ANTITUMOR EFFECTOR CELLS | authKW | 50891 | 0% | 100% | 1 |
10 | BALGAT HLTH MOUTH TEETH | address | 50891 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Otorhinolaryngology | 12896 | 31% | 0% | 186 |
2 | Oncology | 3203 | 38% | 0% | 230 |
3 | Immunology | 755 | 18% | 0% | 110 |
4 | Medicine, Research & Experimental | 611 | 13% | 0% | 77 |
5 | Surgery | 608 | 19% | 0% | 112 |
6 | Dentistry, Oral Surgery & Medicine | 327 | 6% | 0% | 38 |
7 | Pathology | 39 | 3% | 0% | 18 |
8 | Cell Biology | 7 | 4% | 0% | 24 |
9 | Pharmacology & Pharmacy | 4 | 5% | 0% | 27 |
10 | Medical Laboratory Technology | 3 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SERV 151Z2 | 178112 | 1% | 50% | 7 |
2 | AN GANG GEN HOSP | 50891 | 0% | 100% | 1 |
3 | BALGAT HLTH MOUTH TEETH | 50891 | 0% | 100% | 1 |
4 | BERGEN BROEGELMANN | 50891 | 0% | 100% | 1 |
5 | BERNALILLO CTY MED MED PATHOL | 50891 | 0% | 100% | 1 |
6 | BIOL CLIN ENDOCRINOL | 50891 | 0% | 100% | 1 |
7 | BROEGELMANNS IMMUNOL | 50891 | 0% | 100% | 1 |
8 | CELL CANC BIOL INTERVENT SECT | 50891 | 0% | 100% | 1 |
9 | CHAIR SERV CHEMOTHER Y | 50891 | 0% | 100% | 1 |
10 | CLIN OTORHINOLARINGOIATR | 50891 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | 14396 | 7% | 1% | 43 |
2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 11975 | 5% | 1% | 32 |
3 | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 4634 | 4% | 0% | 21 |
4 | LARYNGOSCOPE | 3981 | 5% | 0% | 32 |
5 | JOURNAL OF IMMUNOTHERAPY | 2436 | 2% | 1% | 9 |
6 | OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2251 | 4% | 0% | 21 |
7 | ORAL ONCOLOGY | 2026 | 2% | 0% | 11 |
8 | CANCER DRUG DELIVERY | 1751 | 0% | 2% | 2 |
9 | RADIATION ONCOLOGY INVESTIGATIONS | 1129 | 0% | 2% | 1 |
10 | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY | 1052 | 2% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHIBUYA, TY , KIM, S , NGUYEN, K , PARIKH, P , WADHWA, A , BROCKARDT, C , DO, J , (2003) COVALENT LINKING OF PROTEINS AND CYTOKINES TO SUTURE: ENHANCING THE IMMUNE RESPONSE OF HEAD AND NECK CANCER PATIENTS.LARYNGOSCOPE. VOL. 113. ISSUE 11. P. 1870-1884 | 57 | 54% | 10 |
2 | HADDEN, JW , (1995) IMMUNOLOGY OF HEAD AND NECK-CANCER - PROSPECTS FOR IMMUNOTHERAPY.CLINICAL IMMUNOTHERAPEUTICS. VOL. 3. ISSUE 5. P. 362-385 | 71 | 40% | 11 |
3 | WUSTROW, TPU , ISSING, WJ , (1993) IMMUNE DEFECTS IN PATIENTS WITH HEAD AND NECK-CANCER.ANTICANCER RESEARCH. VOL. 13. ISSUE 6B. P. 2507-2519 | 49 | 56% | 10 |
4 | HADDEN, JW , (1997) THE IMMUNOPHARMACOLOGY OF HEAD AND NECK CANCER: AN UPDATE.INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. VOL. 19. ISSUE 11-12. P. 629 -644 | 49 | 42% | 31 |
5 | FEINMESSER, M , OKON, E , SCHWARTZ, A , KAGANOVSKY, E , HARDY, B , AMINOV, E , NAGERIS, B , SULKES, J , FEINMESSER, R , (2004) HISTOLOGIC AND IMMUNOHISTOCHEMICAL CHARACTERIZATION OF TUMOR AND INFLAMMATORY INFILTRATES IN ORAL SQUAMOUS CELL CARCINOMAS TREATED WITH LOCAL MULTIKINE IMMUNOTHERAPY: THE MACROPHAGE AT THE FRONT LINE.EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. VOL. 261. ISSUE 7. P. 359-368 | 22 | 61% | 13 |
6 | LATHERS, DMR , CLARK, JI , ACHILLE, NJ , YOUNG, MRI , (2004) PHASE 1B STUDY TO IMPROVE IMMUNE RESPONSES IN HEAD AND NECK CANCER PATIENTS USING ESCALATING DOSES OF 25-HYDROXYVITAMIN D-3.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 53. ISSUE 5. P. 422-430 | 19 | 61% | 50 |
7 | HOFFMANN, TK , BIER, H , WHITESIDE, TL , (2004) TARGETING THE IMMUNE SYSTEM: NOVEL THERAPEUTIC APPROACHES IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 53. ISSUE 12. P. 1055-1067 | 38 | 30% | 27 |
8 | NITSCH, SM , PRIES, R , WOLLENBERG, B , (2007) HEAD AND NECK CANCER TRIGGERS INCREASED IL-6 PRODUCTION OF CD34+STEM CELLS FROM HUMAN CORD BLOOD.IN VIVO. VOL. 21. ISSUE 3. P. 493-498 | 17 | 61% | 8 |
9 | PRIES, R , WOLLENBERG, B , (2006) CYTOKINES IN HEAD AND NECK CANCER.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 17. ISSUE 3. P. 141 -146 | 22 | 43% | 51 |
10 | BERINSTEIN, NL , WOLF, GT , NAYLOR, PH , BALTZER, L , EGAN, JE , BRANDWEIN, HJ , WHITESIDE, TL , GOLDSTEIN, LC , EL-NAGGAR, A , BADOUAL, C , ET AL (2012) INCREASED LYMPHOCYTE INFILTRATION IN PATIENTS WITH HEAD AND NECK CANCER TREATED WITH THE IRX-2 IMMUNOTHERAPY REGIMEN.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 61. ISSUE 6. P. 771-782 | 17 | 50% | 6 |
Classes with closest relation at Level 1 |